Eyenovia, Inc. (EYEN)
Automate Your Wheel Strategy on EYEN
With Tiblio's Option Bot, you can configure your own wheel strategy including EYEN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol EYEN
- Rev/Share 0.0503
- Book/Share -11.4876
- PB -0.1454
- Debt/Equity -0.8584
- CurrentRatio 0.1725
- ROIC 25.3459
- MktCap 4814293.0
- FreeCF/Share -26.5635
- PFCF -0.159
- PE -0.0382
- Debt/Assets 3.0649
- DivYield 0
- ROE 20.0703
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol ® water-free drug delivery technology for glaucoma with Eyenovia's Optejet ® device platform
Read More
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet® device, today announced that it has been informed by staff of The Nasdaq Stock Market LLC that the Company has regained compliance with all Nasdaq Capital Market continued listing requirements, including Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement rule, and Listing Rule 5810(c)(3)(A)(iii), the low priced stocks rule.
Read More
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
Amendment provides financial flexibility to the Company by deferring all interest as well as principal redemption payments through September 2025, while reducing near-term cash needs Amendment provides financial flexibility to the Company by deferring all interest as well as principal redemption payments through September 2025, while reducing near-term cash needs
Read More
About Eyenovia, Inc. (EYEN)
- IPO Date 2018-01-25
- Website https://www.eyenovia.com
- Industry Biotechnology
- CEO Mr. Michael M. Rowe
- Employees 13